Vanda Pharmaceuticals says its schizophrenia drug works in bipolar disorder

“We believe this is really critical data to ask for an FDA approval,” said Vanda’s president and CEO.

Source: bizjournals.com Health Care:Biotechnology headlines - December 19, 2022 Category: Biotechnology Authors: Sara Gilgore Source Type: news